Jinhai Medical Technology Limited (HKG: 2225)
Hong Kong
· Delayed Price · Currency is HKD 6.05
+0.02 (0.33%)
Sep 27, 2024, 4:08 PM HKT
Jinhai Medical Technology Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 59.6 | 45.64 | 22.28 | 21.9 | 22.47 | 51.9 | Upgrade
|
| Revenue Growth (YoY) | 204.76% | 104.87% | 1.75% | -2.56% | -56.70% | 9.36% | Upgrade
|
| Cost of Revenue | 45.2 | 33.62 | 12.16 | 14.17 | 13.62 | 39.52 | Upgrade
|
| Gross Profit | 14.4 | 12.03 | 10.12 | 7.73 | 8.85 | 12.38 | Upgrade
|
| Selling, General & Admin | 25.04 | 15.95 | 10.25 | 8.71 | 10.61 | 13.25 | Upgrade
|
| Operating Expenses | 25.7 | 16.62 | 10.12 | 9.16 | 10.71 | 13.25 | Upgrade
|
| Operating Income | -11.3 | -4.59 | - | -1.43 | -1.85 | -0.86 | Upgrade
|
| Interest Expense | -0.52 | -0.22 | -0.09 | -0.13 | -0.31 | -0.44 | Upgrade
|
| Interest & Investment Income | 0.35 | 0.36 | 0.45 | 0.18 | 0.03 | 0.09 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.25 | -0.63 | 0.11 | 0.18 | -0.24 | -0.16 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.42 | 2.61 | 0.55 | 0.19 | 0.62 | 0.47 | Upgrade
|
| EBT Excluding Unusual Items | -9.3 | -2.47 | 1.03 | -1.02 | -1.76 | -0.9 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.61 | -1.02 | -0.89 | -0.81 | 0.45 | 0.19 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.02 | -0.02 | 0.15 | 0.28 | 0.14 | 0 | Upgrade
|
| Asset Writedown | - | - | - | -0.08 | 0.04 | -0.07 | Upgrade
|
| Other Unusual Items | 0.1 | 0.19 | 0.32 | 1.49 | 2.35 | 0.71 | Upgrade
|
| Pretax Income | -9.75 | -3.22 | 0.78 | -0.06 | 1.43 | 0.09 | Upgrade
|
| Income Tax Expense | 0.9 | 0.9 | 0.67 | 0.44 | 0.16 | 0.77 | Upgrade
|
| Earnings From Continuing Operations | -10.65 | -4.11 | 0.12 | -0.5 | 1.26 | -0.69 | Upgrade
|
| Minority Interest in Earnings | 0.53 | 0.97 | 0.35 | 0.25 | - | - | Upgrade
|
| Net Income | -10.12 | -3.14 | 0.47 | -0.25 | 1.26 | -0.69 | Upgrade
|
| Net Income to Common | -10.12 | -3.14 | 0.47 | -0.25 | 1.26 | -0.69 | Upgrade
|
| Shares Outstanding (Basic) | 1,274 | 1,243 | 1,230 | 1,230 | 1,230 | 1,230 | Upgrade
|
| Shares Outstanding (Diluted) | 1,274 | 1,243 | 1,230 | 1,230 | 1,230 | 1,230 | Upgrade
|
| Shares Change (YoY) | 3.58% | 1.04% | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.00 | 0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.00 | 0.00 | -0.00 | 0.00 | -0.00 | Upgrade
|
| Free Cash Flow | -1.56 | -3.15 | 3.06 | 2.73 | 7.25 | 7.25 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 24.17% | 26.35% | 45.40% | 35.29% | 39.40% | 23.86% | Upgrade
|
| Operating Margin | -18.96% | -10.06% | - | -6.55% | -8.24% | -1.66% | Upgrade
|
| Profit Margin | -16.99% | -6.88% | 2.10% | -1.12% | 5.62% | -1.32% | Upgrade
|
| Free Cash Flow Margin | -2.62% | -6.89% | 13.75% | 12.48% | 32.25% | 13.98% | Upgrade
|
| EBITDA | -8.57 | -1.33 | 3.57 | 2.33 | 2.15 | 3.17 | Upgrade
|
| EBITDA Margin | -14.38% | -2.90% | 16.03% | 10.62% | 9.58% | 6.11% | Upgrade
|
| D&A For EBITDA | 2.73 | 3.27 | 3.57 | 3.76 | 4 | 4.03 | Upgrade
|
| EBIT | -11.3 | -4.59 | - | -1.43 | -1.85 | -0.86 | Upgrade
|
| EBIT Margin | -18.96% | -10.06% | - | -6.55% | -8.24% | -1.66% | Upgrade
|
| Effective Tax Rate | - | - | 85.20% | - | 11.41% | 901.92% | Upgrade
|
| Revenue as Reported | - | - | - | - | 22.47 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.